Navigation Links
Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
Date:9/14/2007

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- Blue Cross and Blue Shield Association (BCBSA) convened a forum today at the National Press Club in Washington, D.C., to discuss how insurers, doctors and hospitals are working together to improve healthcare quality and patient safety. Representatives from the Premier Inc. healthcare alliance, Duke University Health System, Blue Cross and Blue Shield of Alabama, and WellPoint, Inc., participated in the event.

"Today's forum provides an opportunity to showcase the innovative ways insurers and providers are working together to develop and implement successful practices for delivering patient care that is both safe and effective," said Allan Korn, MD, BCBSA senior vice president and chief medical officer. "Our goal is to accelerate change in decreasing the risk of potential harm to patients in the clinical setting. As today's event demonstrates, this is a shared commitment between the Blues and all healthcare stakeholders."

Based on data collected over several years from multiple partner institutions, the Institute for Healthcare Improvement (IHI) estimates that nearly 15 million instances of medical harm occur in the U.S. each year. That is equal to a rate of more than 40,000 incidents per day.

In late 2006, participating Blue Cross and Blue Shield companies joined IHI in its national campaign to dramatically reduce incidents of medical harm in U.S. hospitals. The Blues are contributing a total of $5 million during 2007-08 as principal stakeholders to advance IHI's 5 Million Lives Campaign, which encourages hospitals to adopt at least one of 12 improvements in care that can protect patients from medical harm.

Today's forum, "Collaborating to Improve Quality and Safety in Healthcare: Results through Shared Commitment" illustrates best practices among healthcare professionals, hospitals and insurers. Participants included:

-- Allan Korn, MD, senior vice president and chief medical offic
'/>"/>

SOURCE Blue Cross and Blue Shield Association
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...e Heart, of System, WASHINGTON, May 12 /PRNewsw...irs (VA), the nation,s largest single employer of ...x of its top professionals., "VA nurses are the...re,system," stated Secretary of Veterans Affairs D... comes from the personal, one-on-one interaction,b...
(Date:5/12/2008)... Fairbank Farms, a national,ground beef producer, ...eef,products produced at its Ashville, N.Y., facil...and Wilson Farms retail outlets and C&S Wholesale,...all pieces of hard plastic. All,recalled products ..., or a,"Julian date 124" on the package,s label. T...
(Date:5/12/2008)...chronized Slides at 5pm Today, LAWRENCE, Mass., M...nc.,(Nasdaq: NXTM ), a leading manufacturer of in...nancial results for the first quarter ended March ... were $31.0 million, compared to,$8.4 million in t...fourth,quarter of 2007. Revenues in the in-center ...
(Date:5/12/2008)...with illegally attaining private,mailing list of S...ilers to,workers, CORALVILLE, Iowa, May 12 /PRN...iation (CNA) violated Iowa state law by improperly...resented by the Service Employees,International Un...on behalf,of nurses today. The suit charges the CN...
Breaking Medicine News(10 mins):Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 3
Better prostate cancer detection,
Prevention is better than cure
...h has shown that folate supplements, widely recomm...he chances of having twins. Professor Judith Lumle...e supplement trials and found women who took folat...ad a 50 per cent greater chance of having twins.//...
... in the retinal vein could not only make you loose...o blocked veins is so painful that the eye may hav...rsity California have devised a new instrument tha...bullets of blockage-dissolving drugs into a clogge...
Other Medicine News:Health News:Blocked viens block eye sight 2
(Date:5/9/2008)... -- Ardea Biosciences, Inc.,(Nasdaq: RDEA ), a co...small- molecule therapeutics for the treatment of ...out, today announced that John W. Beck,has been ap...ons and Chief,Financial Officer effective May 27, ...hortly thereafter. The Company also reported recen...
(Date:5/9/2008)...ws Positive Results with X-ray ...ire/ -- Roche today announced one-year,results fro...MRA(TM),(tocilizumab) can significantly inhibit pr...ts with rheumatoid arthritis (RA), a critical meas... also demonstrated that ACTEMRA,reduces disease si...
(Date:5/8/2008)... -- DATATRAK International, Inc.,(Nasdaq: DATA ),...al,eClinical solutions for the clinical trials ind...e first quarter of 2008., For the three months en...y 41% to $2,088,000 and the Company reported a net...h a basic and diluted basis. These,results compare...
(Date:5/8/2008)...r Research Alliance, an,organization comprised of ...03 million Americans to exercise their power over ...his Mother,s Day through Father,s Day., The campa...o key goals:,to activate Americans everywhere to t...er to exercise their collective power over cancer,...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Clinical depression linked to abnormal emotional brain circuits 46 1Clinical depression linked to abnormal emotional brain circuits 46 2Clinical depression linked to abnormal emotional brain circuits 46 3Drop in breast cancer incidence linked to hormone use not mammograms 44 1Drop in breast cancer incidence linked to hormone use not mammograms 44 2HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 1HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 2HPV vaccine does not appear to be effective for treating pre existing HPV infection 42 3Diabetes appears to increase risk of death for patients with acute coronary syndromes 40 1Diabetes appears to increase risk of death for patients with acute coronary syndromes 40 2
...s in Multiple,Sclerosis May Include Direct Activit...est FTY720 stimulates cells,that may help reduce n...ected by multiple sclerosis , · Separately,...ase II clinical study found that the proportion of...ly lower in the,FTY720 groups compared to placebo ...
...07 - Lux Biosciences,Inc., a privately held biote...almic diseases, announced today that the company,s...the subject of two,presentations at the Associatio...annual meeting, being held May 6-10 in Fort,Lauder...ing given on May 5 during a,satellite session of t...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4
Inquire
Light Diagnostics Measles IgM Capture Enzyme Immunoassay kit is intended for in vitro diagnostic use for the qualitative confirmation of serum IgM to measles virus.
Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of Measles IgM antibodies in human serum. For in vitro diagnostic use. High complexity test.
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo
Medicine Products: